German court dismisses Chiron patent claim versus Roche
This article was originally published in Clinica
Executive Summary
The German district court in Mannheim, Baden-Wurttemberg, has rejected a claim by US company Chiron that the sale by Roche Diagnostics of its COBAS CORE HCV enzyme immunoassay in Germany infringed its patent. The court held that the complaint, filed under European Patent EP 0450931, was not admissible and fully rejected it.